Although only a limited types of cancers have been studied, most malignant tumours that were tested responded to local IL-2 therapy. We are always interested in testing the efficiency of local IL-2 therapy in other types of cancer. Our clinical research is performed with informed consent of the patients under guidance of the local ethnical commission. If you are a doctor and want to cooperate, please contact us at cancerimmunotherapy@yahoo.com!